参考文献/References:
[1] Fulton WFM. Arterial anastomoses in the coronary circulation. I. Anatomical features in normal and diseased hearts demonstrated by stereoarteriography[J]. Scott Med J ,1963,8:420-434.
[2] Wu EB,Brilakis ES,Mashayekhi K,et al. Global chronic total occlusion crossing algorithm:JACC state-of-the-art review[J]. J Am Coll Cardiol,2021,78(8):840-853.
[3] Brilakis ES,Mashayekhi K,Tsuchikane E,et al. Guiding principles for chronic total occlusion percutaneous coronary i ntervention[J]. Circulation,2019,140(5):420-433.
[4] Allahwala UK,Kott K,Bland A,et al. Predictors and prognostic i mplications of well-matured coronary collateral circulation in patients with a chronic total occlusion(CTO)[J]. Int Heart J,2020,61(2):223-230.
[5] Fefer P,Knudtson ML,Cheema AN,et al. Current perspectives on coronary chronic total occlusions:the Canadian Multicenter Chronic Total Occlusions Registry[J]. J Am Coll Cardiol,2012,59(11):991-997.
[6] Waldecker B,Waas W,Haberbosch W,et al. Prevalence and significance of coronary collateral circulation in patients with acute myocardial infarct[J]. Z Kardiol,2002,91(3):243-248.
[7] 侯胜男,崔连群. 侧支循环对急性心肌梗死患者近期预后的影响[J]. 山东大学学报(医学版), 2015,53(12):47-50.
[8] Figueras J,Otaegui I,Marti G,et al. Area at risk and collateral circulation in a first acute myocardial infarction with occluded culprit artery. STEMI vs non-STEMI patients[J]. Int J Cardiol,2018,259:14-19.
[9] Bigler MR,Seiler C. The human coronary collateral circulation,its extracardiac anastomoses and their therapeutic promotion[J]. Int J Mol Sci,2019,20(15):3726.
[10] Bloor CM,Keefe JF,Browne MJ. Intercoronary anastomoses in congenital heart disease[J]. Circulation,1966,33(2):227-231.
[11] Picichè M. Noncoronary collateral myocardial blood flow:the human heart’s forgotten blood supply[J]. Open Cardiovasc Med J,2015,9:105-113.
[12] Hudson CL,Moritz AR,Wearn JT. The extracardiac anastomoses of the coronary arteries[J]. J Exp Med,1932,56(6):919-925.
[13] Loukas M,Hanna M,Chen J,et al. Extracardiac coronary arterial anastomoses[J]. Clin Anat,2011,24(2):137-142.
[14] Risau W. Mechanisms of angiogenesis[J]. Nature,1997,386(6626):671-674.
[15] Arras M,Ito WD,Scholz D,et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb[J]. J Clin Invest,1998,101(1):40-50.
[16] Baum O,Da Silva-Azevedo L,Willerding G,et al. Endothelial NOS is main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration[J]. Am J Physiol Heart Circ Physiol,2004,287(5):H2300-H2308.
[17] Grundmann S,Piek JJ,Pasterkamp G,et al. Arteriogenesis:basic mechanisms and therapeutic stimulation[J]. Eur J Clin Invest,2007,37(10):755-766.
[18] Hoefer IE,van Royen N,Buschmann IR,et al. Time course of arteriogenesis following femoral artery occlusion in the rabbit[J]. Cardiovasc Res,2001,49(3):609-617.
[19] Gloekler S,Meier P,de Marchi SF,et al. Coronary collateral growth by external counterpulsation:a randomised controlled trial[J]. Heart,2010,96(3):202-207.
[20] Pipp F,Boehm S,Cai WJ,et al. Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb[J]. Arterioscler Thromb Vasc Biol,2004,24(9):1664-1668.
[21] Schaper W. Collateral circulation:past and present[J]. Basic Res Cardiol,2009,104(1):5-21.
[22] van Royen N,Piek JJ,Schaper W,et al. A critical review of clinical arteriogenesis research[J]. J Am Coll Cardiol,2009,55(1):17-25.
[23] Jamaiyar A,Juguilon C,Dong F,et al. Cardioprotection during ischemia by coronary collateral growth[J]. Am J Physiol Heart Circ Physiol,2019,316(1):H1-H9.
[24] Zhang H,Prabhakar P,Sealock R,et al. Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke[J]. J Cereb Blood Flow Metab,2010,30(5):923-934.
[25] Mac Gabhann F,Peirce SM. Collateral capillary arterialization following arteriolar ligation in murine skeletal muscle[J]. Microcirculation,2010,17(5):333-347.
[26] Gouin KH 3rd,Hellstrom SK,Clegg LE,et al. Arterialized collateral capillaries progress from nonreactive to capable of increasing perfusion in an ischemic arteriolar tree[J]. Microcirculation,2018,25(3):e12438.
[27] Zhang H,Faber JE. De-novo collateral formation following acute myocardial infarction:dependence on CCR2? bone marrow cells[J]. J Mol Cell Cardiol,2015,87:4-16.
[28] Aghajanian A,Zhang H,Buckley BK,et al. Decreased inspired oxygen stimulates de novo formation of coronary collaterals in adult heart[J]. J Mol Cell Cardiol ,2021,150:1-11.
[29] Matsuo H,Watanabe S,Kadosaki T,et al. Validation of collateral fractional flow reserve by myocardial perfusion imaging[J]. Circulation,2002,105(9):1060-1065.
[30] Dong W,Li J,Mi H,et al. Relationship between collateral circulation and myocardial viability of 18F-FDG PET/CT subtended by chronic total occluded coronary arteries[J]. Ann Nucl Med,2018,32(3):197-205.
[31] 粟佳男,张丽君,贺毅,等. 冠状动脉慢性完全闭塞病变患者侧支循环与存活心肌之间的关系[J]. 中华心血管病杂志,2017,45(7):579-584.
[32] Sugaya T,Oyama-Manabe N,Yamaguchi T,et al. Visualization of collateral channels with coronary computed tomography angiography for the retrograde approach in percutaneous coronary intervention for chronic total occlusion[J]. J Cardiovasc Comput Tomogr,2016,10(2):128-134.
[33] Rentrop KP,Cohen M,Blanke H,et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects[J]. J Am Coll Cardiol,1985,5(3):587-592.
[34] Vogel R,Zbinden R,Indermühle A,et al. Collateral-flow measurements in humans by myocardial contrast echocardiography:validation of coronary pressure-derived collateral-flow assessment[J]. Eur Heart J,2006,27(2):157-165.
[35] Kajiya T,Yamashita M,Otsuji H,et al. Assessment of coronary collateral artery by CT angiography in patients with ST-elevation acute myocardial infarction[J]. Int J Cardiol,2014,176(3):1359-1361.
[36] Seiler C,Stoller M,Pitt B,et al. The human coronary collateral circulation:development and clinical importance[J]. Eur Heart J,2013,34(34):2674-2682.
[37] Charney R,Cohen M. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size[J]. Am Heart J,1993,126(4):937-945.
[38] Habib GB,Heibig J,Forman SA,et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phaseⅠthrombolysis in myocardial infarction(TIMI) trial. The TIMI Investigators[J]. Circulation,1991,83(3):739-746.
[39] Alsanjari O,Chouari T,Williams T,et al. Angiographically visible coronary artery collateral circulation improves prognosis in patients presenting with acute ST segment-elevation myocardial infarction[J]. Catheter Cardiovasc Interv,2020,96(3):528-533.
[40] Rissanen TT,Yl?-Herttuala S. Current status of cardiovascular gene therapy[J]. Mol Ther,2007,15(7):1233-1247.
[41] Zhu H,Jiang X,Li X,et al. Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction[J]. Heart Vessels,2016,31(6):963-975.
[42] Fisher SA,Brunskill SJ,Doree C,et al. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure[J]. Cochrane Database Syst Rev,2014(4):CD007888.
[43] Kawamura M,Miyagawa S,Fukushima S,et al. Xenotransplantation of bone marrow-derived human mesenchymal stem cell sheets attenuates left ventricular remodeling in a porcine ischemic cardiomyopathy model[J]. Tissue Eng Part A,2015,21(15-16):2272-2280.
[44] Ishida O,Hagino I,Nagaya N,et al. Adipose-derived stem cell sheet transplantation therapy in a porcine model of chronic heart failure[J]. Transl Res,2015,165(5):631-639.
[45] Arutyunyan I,Elchaninov A,Makarov A,et al. Umbilical cord as prospective source for mesenchymal stem cell-based therapy[J]. Stem Cells Int,2016,2016:6901286.
[46] Wang N,Chen C,Yang D,et al. Mesenchymal stem cells-derived extracellular vesicles,via miR-210,improve infarcted cardiac function by promotion of angiogenesis[J]. Biochim Biophys Acta Mol Basis Dis,2017,1863(8):2085-2092.
[47] Nasser MI,Masood M,Adlat S,et al. Mesenchymal stem cell-derived exosome microRNA as therapy for cardiac ischemic injury[J]. Biomed Pharmacother,2021,143:112118.
[48] Gallet R,Dawkins J,Valle J,et al. Exosomes secreted by cardiosphere-derived cells reduce scarring,attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction[J]. Eur Heart J,2017,38(3):201-211.
[49] Kervadec A,Bellamy V,El Harane N,et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure[J]. J Heart Lung Transplant,2016,35(6):795-807.
[50] 朱梓铭. 养心通脉有效部位方干预AMI大鼠BMSCs分化microRNA机制研究[D]. 南宁: 广西中医药大学,2019.
[51] 王家伟. 黄芪甲苷促进骨髓间充质干细胞向周细胞分化及其机制研究[D]. 西安: 中国人民解放军空军军医大学,2018.
[52] 陈岩岩. 从“心主血脉”思想探讨益气通阳逐瘀生新法组方促心肌缺血再灌注大鼠血管新生机理[D]. 长沙: 湖南中医药大学,2021.
[53] Bruning RS,Sturek M. Benefits of exercise training on coronary blood flow in coronary artery disease patients[J]. Prog Cardiovasc Dis,2015,57(5):443-453.
[54] Epstein SE,Stabile E,Kinnaird T,et al. Janus phenomenon:the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis[J]. Circulation,2004,109(23):2826-2831.
[55] Meier P,Gloekler S,de Marchi SF,et al. Myocardial salvage through coronary collateral growth by granulocyte colony-stimulating factor in chronic coronary artery disease:a controlled randomized trial[J]. Circulation,2009,120(14):1355-1363.
[56] Buschmann IR,Hoefer IE,van Royen N,et al. GM-CSF:a strong arteriogenic factor acting by amplification of monocyte function[J]. Atherosclerosis,2001,159(2):343-356.
[57] Seiler C,Pohl T,Wustmann K,et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized,double-blind,placebo-controlled study[J]. Circulation,2001,104(17):2012-2017.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(5):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(5):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(5):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(5):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(5):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(5):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(5):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(5):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]